<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CAR</journal-id>
<journal-id journal-id-type="hwp">spcar</journal-id>
<journal-title>Cartilage</journal-title>
<issn pub-type="ppub">1947-6035</issn>
<issn pub-type="epub">1947-6043</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1947603511414178</article-id>
<article-id pub-id-type="publisher-id">10.1177_1947603511414178</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Characteristic Markers of the WNT Signaling Pathways Are Differentially Expressed in Osteoarthritic Cartilage</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Thorfve</surname><given-names>A.</given-names></name>
<xref ref-type="aff" rid="aff1-1947603511414178">1</xref>
<xref ref-type="aff" rid="aff2-1947603511414178">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dehne</surname><given-names>T.</given-names></name>
<xref ref-type="aff" rid="aff3-1947603511414178">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lindahl</surname><given-names>A.</given-names></name>
<xref ref-type="aff" rid="aff1-1947603511414178">1</xref>
<xref ref-type="aff" rid="aff2-1947603511414178">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Brittberg</surname><given-names>M.</given-names></name>
<xref ref-type="aff" rid="aff4-1947603511414178">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pruss</surname><given-names>A.</given-names></name>
<xref ref-type="aff" rid="aff5-1947603511414178">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ringe</surname><given-names>J.</given-names></name>
<xref ref-type="aff" rid="aff3-1947603511414178">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sittinger</surname><given-names>M.</given-names></name>
<xref ref-type="aff" rid="aff3-1947603511414178">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Karlsson</surname><given-names>C.</given-names></name>
<xref ref-type="aff" rid="aff1-1947603511414178">1</xref>
<xref ref-type="aff" rid="aff2-1947603511414178">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1947603511414178"><label>1</label>Department of Clinical Chemistry and Transfusion Medicine, Institute of Laboratory Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden</aff>
<aff id="aff2-1947603511414178"><label>2</label>BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, Gothenburg, Sweden</aff>
<aff id="aff3-1947603511414178"><label>3</label>Department of Rheumatology and Clinical Immunology, Tissue Engineering Laboratory and Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany</aff>
<aff id="aff4-1947603511414178"><label>4</label>Department of Orthopaedics, Sahlgrenska University Hospital, Gothenburg, Sweden</aff>
<aff id="aff5-1947603511414178"><label>5</label>Institute of Transfusion Medicine, Tissue Bank, Charité-Universitätsmedizin Berlin, Berlin, Germany</aff>
<author-notes>
<corresp id="corresp1-1947603511414178">A. Thorfve, Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden Email: <email>anna.thorfve@medic.gu.se</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>3</volume>
<issue>1</issue>
<fpage>43</fpage>
<lpage>57</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><italic>Objective</italic>: It is well known that expression of markers for WNT signaling is dysregulated in osteoarthritic (OA) bone. However, it is still not fully known if the expression of these markers also is affected in OA cartilage. The aim of this study was therefore to examine this issue. <italic>Methods</italic>: Human cartilage biopsies from OA and control donors were subjected to genome-wide oligonucleotide microarrays. Genes involved in WNT signaling were selected using the BioRetis database, KEGG pathway analysis was searched using DAVID software tools, and cluster analysis was performed using Genesis software. Results from the microarray analysis were verified using quantitative real-time PCR and immunohistochemistry. In order to study the impact of cytokines for the dysregulated WNT signaling, OA and control chondrocytes were stimulated with interleukin-1 and analyzed with real-time PCR for their expression of WNT-related genes. <italic>Results</italic>: Several WNT markers displayed a significantly altered expression in OA compared to normal cartilage. Interestingly, inhibitors of the canonical and planar cell polarity WNT signaling pathways displayed significantly increased expression in OA cartilage, while the Ca<sup>2+</sup>/WNT signaling pathway was activated. Both real-time PCR and immunohistochemistry verified the microarray results. Real-time PCR analysis demonstrated that interleukin-1 upregulated expression of important WNT markers. <italic>Conclusions</italic>: WNT signaling is significantly affected in OA cartilage. The result suggests that both the canonical and planar cell polarity WNT signaling pathways were partly inhibited while the Ca<sup>2+</sup>/WNT pathway was activated in OA cartilage.</p>
</abstract>
<kwd-group>
<kwd>articular cartilage &lt; tissue</kwd>
<kwd>biopsy &lt; research methods</kwd>
<kwd>osteoarthritis &lt; diagnosis</kwd>
<kwd>signaling molecules &lt; cytokines and growth factors</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1947603511414178" sec-type="intro">
<title>Introduction</title>
<p>Osteoarthritis (OA) is the most common form of arthritis and has a prevalence of about 10% in people over 55 years of age.<sup><xref ref-type="bibr" rid="bibr1-1947603511414178">1</xref></sup> The hallmark of OA involves joint pain and reduced mobility that is caused by erosion of the cartilage extracellular matrix and alterations in the underlying bone. Although the extracellular matrix is the functional element in articular cartilage and its degradation is central in the pathogenic process in OA, there is now abundant evidence that chondrocytes play a critical role in cartilage degeneration. For instance, OA chondrocytes secrete a variety of enzymes and cytokines, resulting in cleavage of type II collagen.<sup><xref ref-type="bibr" rid="bibr2-1947603511414178">2</xref></sup> OA chondrocytes, compared to normal chondrocytes, are further in another differentiation state, detected by their increased expression of collagen types I, III, and X.<sup><xref ref-type="bibr" rid="bibr3-1947603511414178">3</xref></sup> Therefore, increasing the knowledge about the cellular alterations in OA chondrocytes is essential for generating new therapies for patients suffering from OA.</p>
<p>WNT signaling has been shown to regulate crucial aspects of cell fate determination, cell migration, cell polarity, and organogenesis during embryonic development and is therefore of importance to study in OA cartilage. WNT regulates at least 3 distinct signaling pathways; the canonical β-catenin pathway regulates cell fate determination, while the 2 noncanonical pathways (planar cell polarity and Ca<sup>2+</sup>/WNT pathway) control cell movement and tissue polarity.<sup><xref ref-type="bibr" rid="bibr4-1947603511414178">4</xref></sup> Signaling through these 3 different WNT pathways is dependent upon WNTs, which are secreted glycoproteins. Today, 19 different WNT proteins have been discovered that bind to several different types of receptors, but the most widely recognized WNT receptors are the frizzled proteins (FZD). The FZD receptors are 7-transmembrane–spanning proteins and constitute a family of at least 10 different G protein–coupled receptors. Downstream of this ligand-receptor interaction, the 3 WNT signaling pathways diverge. With regard to the canonical WNT signaling, FZD coreceptors such as LRP5/6 are also required for translocation of the signal. Several secreted WNT antagonists, such as DKK, SFRP, and WIF, exert a key level of regulation of canonical WNT signaling. The activation of FZD and LRP5/6 triggers phosphorylation of DVL, which disrupts the β-catenin degradation complex, consisting of AXIN, APC, and GSK-3β. This complex normally degrades β-catenin through phosphorylation; however, when WNTs bind FZD, β-catenin levels are stabilized and translocated into the nucleus, resulting in transcription of downstream canonical WNT markers. The noncanonical pathways are less studied. They function independently of β-catenin.<sup><xref ref-type="bibr" rid="bibr5-1947603511414178">5</xref></sup> Still, the FZD receptor is of importance for signaling but also coreceptors such as ROR2 and RYK, but not LRP5/6.<sup><xref ref-type="bibr" rid="bibr6-1947603511414178">6</xref></sup></p>
<p>A few studies have been performed investigating the expression of WNT markers during cartilage development, demonstrating an altered expression depending on the differentiation state of the chondrocytes.<sup><xref ref-type="bibr" rid="bibr7-1947603511414178">7</xref>-<xref ref-type="bibr" rid="bibr12-1947603511414178">12</xref></sup> Compared to the knowledge obtained concerning the importance of WNT signaling during cartilage development, relatively little is known regarding the role of WNT signaling in the maintenance and destruction of cartilage. Interleukin-1 is known to increase cartilage matrix degradation, and chondrocytes stimulated with this cytokine increase their expression of WNT5A while decreasing their expression of WNT11.<sup><xref ref-type="bibr" rid="bibr13-1947603511414178">13</xref></sup> Further evidence for the importance of WNT signaling in OA cartilage is the increased levels of β-catenin in chondrocytes within areas of degenerative cartilage.<sup><xref ref-type="bibr" rid="bibr14-1947603511414178">14</xref>,<xref ref-type="bibr" rid="bibr15-1947603511414178">15</xref></sup> Moreover, microarray analysis of the underlying bone suggests that the WNT network is altered in OA bone and may play a role(s) in OA pathogenesis.<sup><xref ref-type="bibr" rid="bibr16-1947603511414178">16</xref></sup></p>
<p>Differential regulation of WNT markers during cartilage development, recent findings concerning the importance of WNT signaling for OA, as well as the shortage of knowledge regarding the expression pattern of WNT markers in OA cartilage prompted us to comprehensively investigate the expression of WNT markers in human OA cartilage. We have earlier reported a broad gene expression comparison of human OA and normal donor cartilage and here use this unique database to focus on investigating the expression of WNT markers.<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup> This knowledge will expand our current understanding of OA pathogenesis and provide relevant insight into the phenotypical alterations and mechanisms involved in OA pathogenesis.</p>
</sec>
<sec id="section2-1947603511414178" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-1947603511414178">
<title>Collection of Biopsies</title>
<p>Cartilage biopsies from 5 OA patients (74 ± 8 years old) undergoing total knee replacement and 8 control donors (57 ± 16 years old) with macroscopically healthy cartilage and with a Mankin score ≤1 were collected from organ donors (24-48 hours, <italic>post mortem</italic>) (normal donors [NDs]) as described earlier.<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup> These biopsies were further used for immunohistological detection of WNT markers (see below). The rest of the biopsies were used for RNA isolation and subsequent microarray analysis. ND and OA cartilage was also collected for subsequent cell cultures. The donation of cartilage was approved by the ethical committees at the Medical Faculties at Gothenburg University and Charité-Universitätsmedizin Berlin.</p>
</sec>
<sec id="section4-1947603511414178">
<title>RNA Isolation</title>
<p>Cartilage biopsies were processed for RNA isolation.<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup> Briefly, after mechanical disruption, isolation of total RNA was performed using the Qiagen RNeasy Mini Kit (Hilden, Germany), and the integrity and purity were analyzed using the Agilent Bioanalyzer and NanoDrop spectrophotometer (Santa Clara, CA). All samples were of similar RNA quality and integrity with limited signs of degradation typical for primary tissues.</p>
</sec>
<sec id="section5-1947603511414178">
<title>Microarray Analysis</title>
<p>Gene expression was performed using Affymetrix oligonucleotide microarray HG-U133plus2.0 (Santa Clara, CA) according to the manufacturer’s recommendations, as previously described.<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup> Genes were regarded as differentially expressed when fulfilling specific change call criteria. In this study, the limit was set to at least ≥75% possible significant change calls. Functional classification of genes involved in WNT signaling was conducted with annotations from the Gene Ontology Annotation Database.<sup><xref ref-type="bibr" rid="bibr18-1947603511414178">18</xref></sup> Downstream <italic>t</italic> test statistics applying the Welch test on log<sub>2</sub>-transformed signal values were performed to obtain a significance level. Expression differences were given as fold changes (FCs); only significantly altered genes that displayed a mean fold change of FC ≥2 or ≤−2 were selected for further analysis. Hierarchical cluster analysis was performed as described previously.<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup></p>
</sec>
<sec id="section6-1947603511414178">
<title>Pathway Analysis</title>
<p>In order to identify significant differently expressed pathways in OA and ND cartilage, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database<sup><xref ref-type="bibr" rid="bibr19-1947603511414178">19</xref></sup> was searched using DAVID software tools.<sup><xref ref-type="bibr" rid="bibr20-1947603511414178">20</xref>,<xref ref-type="bibr" rid="bibr21-1947603511414178">21</xref></sup> All genes on the array fulfilling the specific criteria used in this study (see above) were included in the gene list.</p>
</sec>
<sec id="section7-1947603511414178">
<title>Quantitative Real-Time PCR Analysis</title>
<p>The following assay-on-demand mixes were used from Applied Biosystems (Foster City, CA) (order number in parentheses): <italic>DKK1</italic> (Hs00183740_m1), <italic>FOSL1</italic> (Hs00759776_s1), <italic>FZD1</italic> (Hs00268943_s1), <italic>SFRP4</italic> (Hs00180066_m1), <italic>WNT5A</italic> (Hs00180103_m1), which were all FAM dye labeled. 18s rRNA (4310893E) labeled with VIC/TAMRA was used as endogenous control. PCR was performed with the Applied Biosystems 7900HT real-time PCR System. cDNA from 6 NDs and 5 OA donors, corresponding to 1 ng total RNA isolated from the cartilage biopsies, and 2.5 ng total RNA from the monolayer cultured cells isolated from 3 NDs and 3 OA donors were analyzed in duplicates. Raw data were analyzed by using SDS v2.2.2 software (Applied Biosystems), and the 2<sup>–ΔΔCt</sup> value was used to obtain the gene expression for each particular gene. Statistical analysis was performed using the Mann-Whitney <italic>U</italic> test (cartilage biopsies) and Wilcoxon paired signed-rank test (monolayer cultured cells). Values of <italic>P</italic> &lt; 0.05 were considered to indicate statistically significant differences.</p>
</sec>
<sec id="section8-1947603511414178">
<title>Immunohistochemistry</title>
<p>Immunohistochemistry was performed on 5 OA and 4 ND sections in duplicates from articular cartilage for AXIN2, DKK1, DKK3, and WNT5A. Slides for labeling with AXIN2 and DKK3 were digested with trypsin 0.05% EDTA, while labeling with DKK1 and WNT5A was preceded by protease treatment (1 mg/mL; Sigma-Aldrich, St. Louis, MO). Additional enzyme treatment with hyaluronidase (8000 U/mL; Sigma-Aldrich) was performed for DKK1. The sections were blocked with 3% BSA. Primary antibodies (rabbit polyclonal anti-AXIN2, rabbit polyclonal anti-DKK, rabbit polyclonal anti-DKK3, and goat polyclonal anti-WNT5A) were purchased from Abcam (Cambridge, MA), Sigma-Aldrich, and R&amp;D Systems (Minneapolis, MN), respectively. An isotype control for each primary antibody was used as control: normal rabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA) for AXIN2 and DKK1 as well as rabbit polyclonal IgG (Abcam) for DKK3 and normal goat IgG for WNT5A. The primary antibodies and the isotype controls were visualized using HRP-conjugated secondary antibodies (sheep anti-rabbit HRP [Millipore, Billerica, MA] and donkey anti-goat HRP). The secondary antibodies were visualized using the TSA-Direct Cy3 kit (Perkin Elmer, Boston, MA) according to the manufacturer’s instructions. The nuclei were stained with 4’,6-diamidino-2-phenylindol (DAPI) (Sigma-Aldrich). Digital pictures were taken with the NIS-Elements D Ver.3.00 (Nikon, Tokyo, Japan).</p>
</sec>
<sec id="section9-1947603511414178">
<title>Analysis of Protein Interaction Networks</title>
<p>To investigate possible interactions among proteins coded by genes that were differentially regulated (defined by having a mean FC ≥3 or ≤−3) between NDs and OA donors, the protein interaction analysis was performed as described previously.<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup></p>
</sec>
<sec id="section10-1947603511414178">
<title>Chondrocyte Isolation</title>
<p>Chondrocytes were isolated from 3 ND and 3 OA cartilage biopsies as described previously.<sup><xref ref-type="bibr" rid="bibr22-1947603511414178">22</xref></sup> The isolated cells were expanded in medium consisting of DMEM/F12 (Invitrogen, Paisley, UK) supplemented with L-ascorbic acid (0.025 mg/mL; Apotekets production unit, Umeå, Sweden), gentamicin sulfate (50 mg/L; Gibco, Paisley, UK), amphotericin B (250 µg/mL), and L-glutamine (2 mM; Gibco) and 10% human serum.</p>
</sec>
<sec id="section11-1947603511414178">
<title>Cytokine Stimulation of Chondrocytes</title>
<p>Chondrocytes, isolated from 3 NDs and 3 OA donors, in passage 1 were stimulated with 10 ng/mL of human recombinant interleukin-1β (Sigma-Aldrich) for 24 hours or left unstimulated. Gene expression of WNT markers was then studied in duplicates using real-time PCR, as described above.</p>
</sec>
</sec>
<sec id="section12-1947603511414178" sec-type="results">
<title>Results</title>
<sec id="section13-1947603511414178">
<title>Characterization of OA and ND Cartilage</title>
<p>For an extensive verification of the NDs and OA phenotypes, see Karlsson <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup> Briefly, all OA donors displayed an Ahlbäck score of 2 to 3. Mankin scoring of the cartilage biopsies demonstrated significant differences between ND and OA articular cartilage biopsies (0.8 ± 0.15 and 6.4 ± 1.3, respectively).</p>
</sec>
<sec id="section14-1947603511414178">
<title>Pathway Analysis in OA versus ND Cartilage</title>
<p>In order to explore pathways that could be differentially expressed in OA versus ND cartilage, the KEGG pathway database was searched using the genes regarded as significantly differentially expressed as input. The analysis demonstrated 26 pathways that show a significantly different expression in OA compared to ND cartilage, whereas 10 of the most significantly expressed pathways are listed in <xref ref-type="table" rid="table1-1947603511414178"><bold>Table 1</bold></xref>. The presence of the WNT signaling pathway demonstrates that the WNT network is dysregulated in OA compared to ND cartilage.</p>
<table-wrap id="table1-1947603511414178" position="float">
<label>Table 1.</label>
<caption>
<p>Differentially Expressed Pathways in Osteoarthritic (OA) versus Normal Donor (ND) Cartilage</p>
</caption>
<graphic alternate-form-of="table1-1947603511414178" xlink:href="10.1177_1947603511414178-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">KEGG ID</th>
<th align="center">Pathway Term</th>
<th align="center">Count</th>
<th align="center"><italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>hsa04512</td>
<td>Extracellular matrix receptor interaction</td>
<td>29</td>
<td>9.28E-10</td>
</tr>
<tr>
<td>hsa04510</td>
<td>Focal adhesion</td>
<td>43</td>
<td>4.12E-7</td>
</tr>
<tr>
<td>hsa05130</td>
<td>Pathogenic <italic>Escherichia coli</italic> infection</td>
<td>18</td>
<td>1.10E-5</td>
</tr>
<tr>
<td>hsa05200</td>
<td>Pathways in cancer</td>
<td>52</td>
<td>1.81E-4</td>
</tr>
<tr>
<td>hsa05222</td>
<td>Small cell lung cancer</td>
<td>18</td>
<td>1.81E-3</td>
</tr>
<tr>
<td>hsa04810</td>
<td>Regulation of actin cytoskeleton</td>
<td>34</td>
<td>3.11E-3</td>
</tr>
<tr>
<td>hsa04310</td>
<td>Wnt signaling pathway</td>
<td>26</td>
<td>3.53E-3</td>
</tr>
<tr>
<td>hsa04115</td>
<td>p53 signaling pathway</td>
<td>15</td>
<td>3.81E-3</td>
</tr>
<tr>
<td>hsa04722</td>
<td>Neurotrophin signaling pathway</td>
<td>22</td>
<td>5.53E-3</td>
</tr>
<tr>
<td>hsa05221</td>
<td>Acute myeloid leukemia</td>
<td>13</td>
<td>6.87E-3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1947603511414178">
<p>Note: Pathway analysis using the KEGG pathway database with significantly different expression in OA compared to ND cartilage. Only 10 (of 26) of the most significant differentially expressed pathways are shown. Count indicates the total number of genes from the input list that belong to the corresponding term; only significantly expressed genes that displayed a mean fold change (FC) of ≥2 or ≤−2 were included in the gene list.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section15-1947603511414178">
<title>WNT Markers Are Differentially Regulated in OA Cartilage</title>
<p>Due to the results obtained from the KEGG pathway analysis, a cluster analysis was performed of all genes denoted to be involved in WNT signaling. The analysis revealed 2 distinct clusters, one with OA cartilage and one with ND cartilage (<xref ref-type="fig" rid="fig1-1947603511414178"><bold>Fig. 1</bold></xref>). These separate clusters thus demonstrate that the expression of WNT markers is significantly altered in OA cartilage.</p>
<fig id="fig1-1947603511414178" position="float">
<label>Figure 1.</label>
<caption>
<p>Hierarchical cluster analysis of genes involved in WNT signaling. Hierarchical cluster analysis of genes known to be associated with WNT signaling demonstrated that cartilage from the 5 donors with normal cartilage (ND1-ND5) formed one cluster and cartilage from osteoarthritic donors (OA1-OA5) formed another cluster, showing significantly altered WNT signaling in OA cartilage.</p>
</caption>
<graphic xlink:href="10.1177_1947603511414178-fig1.tif"/>
</fig>
</sec>
<sec id="section16-1947603511414178">
<title>Increased Expression of Genes Encoding Inhibitors of the WNT Signaling Pathway in OA Cartilage</title>
<p>Our results from the microarray analysis demonstrate that the expression of 32 genes associated with WNT signaling was significantly regulated between OA and ND cartilage (<xref ref-type="table" rid="table2-1947603511414178"><bold>Table 2</bold></xref>). Of interest to note is that several inhibitors of the canonical and planar cell polarity WNT signaling pathways displayed an increased expression in OA cartilage. The expression of important extracellular inhibitors of the canonical pathway, including <italic>DKK1</italic>, <italic>DKK3</italic>, <italic>WIF1</italic>, <italic>SFRP1</italic>, and <italic>SFRP4</italic>, was significantly upregulated in the OA biopsies, with a 3.9, 3.9, 3.1, 8.1, and 14.2 FC, respectively. Several homologs of the FZD receptor (<italic>FZD1</italic>, <italic>FZD7</italic>, <italic>FZD8</italic>, and <italic>FZD10</italic>) also displayed increased expression in OA cartilage. Expression of intracellular and intranuclear inhibitors was also upregulated in the OA biopsies, including genes involved in β-catenin phosphorylation and its destruction, such as <italic>AXIN2</italic>, <italic>SOX17</italic>, and <italic>TAX1BP3</italic>. Furthermore, the transcriptional repressor <italic>TLE4</italic> displayed a 2.3-fold higher expression in OA than in ND biopsies, whereas <italic>TCF7L2</italic> was downregulated 2.5-fold. On the other hand, genes transcribed when the canonical WNT signaling is activated, such as <italic>FOSL1</italic> and <italic>PPARD</italic>, exhibited an increased expression in OA cartilage. Our results further demonstrate that the planar cell polarity pathway was inhibited. Expression of several markers for this pathway, such as <italic>PRICKLE2</italic>, <italic>DVL2</italic>, and <italic>DAAM2</italic>, was significantly downregulated 2.1-, 3.4-, and 3.8-fold, respectively, in OA cartilage. However, genes denoted to the Ca<sup>2+</sup>/WNT pathway displayed an increased expression. Among them, <italic>WNT5A</italic>, <italic>CAMKII</italic>, <italic>NFAT5</italic>, and <italic>NFATC2</italic> expression was significantly upregulated 16.0-, 3.2-, 4.3-, and 8.2-fold, respectively, in OA cartilage. These extended microarray results are summarized in <xref ref-type="fig" rid="fig2-1947603511414178"><bold>Figure 2</bold></xref>.</p>
<table-wrap id="table2-1947603511414178" position="float">
<label>Table 2.</label>
<caption>
<p>WNT Related Genes Revealed in the Microarray Analysis</p>
</caption>
<graphic alternate-form-of="table2-1947603511414178" xlink:href="10.1177_1947603511414178-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Gene Name</th>
<th align="center">Gene Symbol</th>
<th align="center">Probe ID</th>
<th align="center">Public ID</th>
<th align="center">FC OA versus ND</th>
<th align="center"><italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6">Extracellular</td>
</tr>
<tr>
<td>Wingless-type MMTV integration site family, member 5</td>
<td>WNT5A</td>
<td>205990_s_at</td>
<td>NM_003392</td>
<td>16.0</td>
<td>6.92735E-15</td>
</tr>
<tr>
<td>Secreted frizzled-related protein 4</td>
<td>SFRP4</td>
<td>204051_s_at</td>
<td>AW089415</td>
<td>14.2</td>
<td>1.38979E-25</td>
</tr>
<tr>
<td>Secreted frizzled-related protein 1</td>
<td>SFRP1</td>
<td>202037_s_at</td>
<td>NM_003012</td>
<td>8.1</td>
<td>1.45767E-12</td>
</tr>
<tr>
<td>Dickkopf homolog 1</td>
<td>DKK1</td>
<td>204602_at</td>
<td>NM_012242</td>
<td>3.9</td>
<td>4.24038E-6</td>
</tr>
<tr>
<td>Dickkopf homolog 3</td>
<td>DKK3</td>
<td>202196_s_at</td>
<td>NM_013253</td>
<td>3.9</td>
<td>1.18684E-5</td>
</tr>
<tr>
<td>WNT inhibitory factor 1</td>
<td>WIF1</td>
<td>204712_at</td>
<td>NM_007191</td>
<td>3.1</td>
<td>2.26111E-5</td>
</tr>
<tr>
<td colspan="6">Membrane bound</td>
</tr>
<tr>
<td>Frizzled homolog 8</td>
<td>FZD8</td>
<td>227405_s_at</td>
<td>AW340311</td>
<td>13.4</td>
<td>8.92757E-26</td>
</tr>
<tr>
<td>Frizzled homolog 10</td>
<td>FZD10</td>
<td>219764_at</td>
<td>NM_007197</td>
<td>6.7</td>
<td>6.72813E-30</td>
</tr>
<tr>
<td>Vang-like 1</td>
<td>VANGL1</td>
<td>219330_at</td>
<td>NM_024062</td>
<td>4.8</td>
<td>5.55668E-17</td>
</tr>
<tr>
<td>Sulfatase 1</td>
<td>SULF1</td>
<td>212353_at</td>
<td>AI479175</td>
<td>4.3</td>
<td>4.29776E-11</td>
</tr>
<tr>
<td>Frizzled homolog 7</td>
<td>FZD7</td>
<td>203706_s_at</td>
<td>NM_003507</td>
<td>4.0</td>
<td>3.13684E-24</td>
</tr>
<tr>
<td>Frizzled homolog 1</td>
<td>FZD1</td>
<td>204452_s_at</td>
<td>AF072872</td>
<td>3.8</td>
<td>3.07887E-13</td>
</tr>
<tr>
<td colspan="6">Intracellular</td>
</tr>
<tr>
<td>Peroxisome proliferator–activated receptor δ</td>
<td>PPARD</td>
<td>242218_at</td>
<td>AI201116</td>
<td>12.8</td>
<td>9.55763E-8</td>
</tr>
<tr>
<td>FOS-like antigen 1</td>
<td>FOSL1</td>
<td>204420_at</td>
<td>BG251266</td>
<td>9.1</td>
<td>3.88083E-11</td>
</tr>
<tr>
<td>Transcript factor NFAT1 isoform C</td>
<td>NFATC2</td>
<td>226991_at</td>
<td>NM_001136021</td>
<td>8.2</td>
<td>4.32651E-13</td>
</tr>
<tr>
<td>Nuclear factor of activated T-cells 5, tonicity responsive</td>
<td>NFAT5</td>
<td>215092_s_at</td>
<td>NM_001113178</td>
<td>4.3</td>
<td>3.4648E-4</td>
</tr>
<tr>
<td>Casein kinase 1 ϵ</td>
<td>CSNK1E</td>
<td>226858_at</td>
<td align="center">—</td>
<td>3.5</td>
<td>2.73695E-8</td>
</tr>
<tr>
<td>Calmodulin-dependent protein kinase II α</td>
<td>CAMK2A</td>
<td>213108_at</td>
<td>NM_015981</td>
<td>3.2</td>
<td>1.36801E-6</td>
</tr>
<tr>
<td>SRY-box 17</td>
<td>SOX17</td>
<td>219993_at</td>
<td>NM_022454</td>
<td>2.7</td>
<td>2.70202E-7</td>
</tr>
<tr>
<td>Transducin-like enhancer of split 4 E (sp1) homolog</td>
<td>TLE4</td>
<td>204872_at</td>
<td>NM_007005</td>
<td>2.3</td>
<td>2.82611E-8</td>
</tr>
<tr>
<td>Axin 2</td>
<td>AXIN2</td>
<td>222696_at</td>
<td>BF684446</td>
<td>2.3</td>
<td>7.11705E-14</td>
</tr>
<tr>
<td>Tax1-binding protein 3</td>
<td>TAX1BP3</td>
<td>209154_at</td>
<td>AF234997</td>
<td>2.1</td>
<td>5.9216E-12</td>
</tr>
<tr>
<td>DIX domain containing 1</td>
<td>DIXDC1</td>
<td>214724_at</td>
<td>AF070621</td>
<td>2.1</td>
<td>5.99097E-16</td>
</tr>
<tr>
<td>F-box and WD repeat domain containing 4</td>
<td>FBXW4</td>
<td>221519_at</td>
<td>AF281859</td>
<td>−2.0</td>
<td>7.8246E-19</td>
</tr>
<tr>
<td>Prickle homolog 2</td>
<td>PRICKLE2</td>
<td>225968_at</td>
<td>BG285881</td>
<td>−2.1</td>
<td>4.51586E-11</td>
</tr>
<tr>
<td>Protein phosphatase 2 regulatory subunit B, α isoform</td>
<td>PPP2R2A</td>
<td>202313_at</td>
<td>NM_002717</td>
<td>−2.1</td>
<td>1.24529E-10</td>
</tr>
<tr>
<td>HMG-box transcription factor 1</td>
<td>HBP1</td>
<td>209102_s_at</td>
<td>AF019214</td>
<td>−2.2</td>
<td>3.19294E-15</td>
</tr>
<tr>
<td>C-terminal–binding protein 2</td>
<td>CTBP2</td>
<td>201218_at</td>
<td>N23018</td>
<td>−2.4</td>
<td>5.83668E-12</td>
</tr>
<tr>
<td>Casein kinase 2, α prime polypeptide</td>
<td>CSNK2A2</td>
<td>203575_at</td>
<td>NM_001896</td>
<td>−2.4</td>
<td>4.59298E-13</td>
</tr>
<tr>
<td>Transcription factor 7–like 2</td>
<td>TCF7L2</td>
<td>216511_s_at</td>
<td align="center">—</td>
<td>−2.5</td>
<td>1.03935E-12</td>
</tr>
<tr>
<td>Disheveled-associated activator of morphogenesis 2</td>
<td>DAAM2</td>
<td>212793_at</td>
<td>BF513244</td>
<td>−3.4</td>
<td>2.16355E-17</td>
</tr>
<tr>
<td>Disheveled, dsh homolog 2</td>
<td>DVL2</td>
<td>218756_at</td>
<td>NM_004422</td>
<td>−3.8</td>
<td>2.2239E-9</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1947603511414178">
<p>Note: Genes whose expression is differentially regulated between osteoarthritic (OA) and normal donor (ND) cartilage and that are associated with WNT signaling. Genes are divided into genes encoding extracellular, transmembrane, and intracellular proteins. Expression differences are given as fold change (FC); only genes with an FC ≥2 or ≤−2 are shown. Genes with a positive FC are upregulated in OA cartilage when compared with ND cartilage.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-1947603511414178" position="float">
<label>Figure 2.</label>
<caption>
<p>Schematic summary of the results obtained from the microarray analysis. Genes in red boxes negatively regulate the WNT signaling pathway, whereas the green boxes indicate a positive regulation of the network. A “±” sign after the gene name refers to a positive (higher gene expression in OA cartilage) or negative (lower gene expression in OA cartilage) fold change (FC) in the microarray analysis.</p>
</caption>
<graphic xlink:href="10.1177_1947603511414178-fig2.tif"/>
</fig>
</sec>
<sec id="section17-1947603511414178">
<title>Increased Gene Expression of FOSL1, FZD8, NFATC2, SFRP1, SFRP4, and WNT5A in OA Cartilage</title>
<p>To verify the microarray data, a quantitative real-time PCR analysis was performed for 7 of the most highly differentially expressed WNT-related genes comparing OA and ND cartilage according to the microarray analysis. The real-time PCR verification demonstrated that the extracellular inhibitors <italic>SFRP1</italic>, <italic>SFRP4</italic>, as well as the ligand <italic>WNT5A</italic> were significantly upregulated in OA cartilage (<xref ref-type="table" rid="table3-1947603511414178"><bold>Table 3</bold></xref>). The intracellular target and effector genes <italic>FOSL1</italic> and <italic>NFATC2</italic> also displayed a significant upregulation in OA cartilage, whereas the receptor <italic>FZD8</italic> displayed a similar trend but not a significant upregulation (<italic>P</italic> = 0.052). On the other hand, no significant difference was detected with regard to the expression of the downstream target gene <italic>PPARD</italic> in OA and ND cartilage (<italic>P</italic> = 0.082) (<xref ref-type="table" rid="table3-1947603511414178"><bold>Table 3</bold></xref>).</p>
<table-wrap id="table3-1947603511414178" position="float">
<label>Table 3.</label>
<caption>
<p>Quantitative PCR Analysis of WNT-Related Genes</p>
</caption>
<graphic alternate-form-of="table3-1947603511414178" xlink:href="10.1177_1947603511414178-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">ND</th>
<th align="center">95% CI</th>
<th align="center">OA</th>
<th align="center">95% CI</th>
<th align="center"><italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>SFRP4</td>
<td>1.0</td>
<td>0.87</td>
<td>33.64</td>
<td>16.98</td>
<td>0.004</td>
</tr>
<tr>
<td>FOSL1</td>
<td>1.0</td>
<td>0.72</td>
<td>14.26</td>
<td>8.29</td>
<td>0.004</td>
</tr>
<tr>
<td>WNT5A</td>
<td>1.0</td>
<td>0.37</td>
<td>10.66</td>
<td>5.55</td>
<td>0.004</td>
</tr>
<tr>
<td>SFRP1</td>
<td>1.0</td>
<td>0.72</td>
<td>8.35</td>
<td>7.67</td>
<td>0.030</td>
</tr>
<tr>
<td>NFATC2</td>
<td>1.0</td>
<td>0.32</td>
<td>7.90</td>
<td>2.54</td>
<td>0.004</td>
</tr>
<tr>
<td>FZD8</td>
<td>1.0</td>
<td>0.74</td>
<td>2.76</td>
<td>0.83</td>
<td>0.052</td>
</tr>
<tr>
<td>PPARD</td>
<td>1.0</td>
<td>0.36</td>
<td>0.58</td>
<td>0.13</td>
<td>0.082</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1947603511414178">
<p>Note: Quantitative real-time PCR verification of genes, which displayed the highest fold change (FC) in this extended microarray analysis. Error presenting the uncertainty with a 95% confidence interval (CI). Cartilage biopsies from 6 normal donors (NDs) and 5 osteoarthritis (OA) donors were studied; each sample was analyzed in duplicates.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section18-1947603511414178">
<title>Increased Protein Expression of AXIN2, DKK1, DKK3, and WNT5A in OA Cartilage</title>
<p>The spatial localization of AXIN2, DKK1, DKK3, and WNT5A was studied in OA and ND cartilage biopsies using immunohistochemistry in order to verify the microarray data. These markers were investigated due to their involvement in inhibiting the canonical WNT pathway (DKK1, DKK3, and AXIN2) as well as activating the Ca<sup>2+</sup> pathway (WNT5A). Expression of AXIN2 and DKK1 in ND cartilage was localized to the uppermost cell layers, whereas their expression was extended to the cells located in the deeper layers in OA cartilage (<xref ref-type="fig" rid="fig3-1947603511414178"><bold>Fig. 3A</bold></xref>-<xref ref-type="fig" rid="fig3-1947603511414178"><bold>D</bold></xref>). Abundant expression of DKK3 and WNT5A was detected in OA cartilage, while a lower expression, somewhat more restricted to the superficial zone, was detected in ND cartilage (<xref ref-type="fig" rid="fig3-1947603511414178"><bold>Fig. 3E</bold></xref>-<xref ref-type="fig" rid="fig3-1947603511414178"><bold>H</bold></xref>).</p>
<fig id="fig3-1947603511414178" position="float">
<label>Figure 3.</label>
<caption>
<p>Verification of the microarray results using immunohistochemistry. Stainings with antibodies against AXIN2 (<bold>A</bold>, <bold>B</bold>), DKK1 (<bold>C</bold>, <bold>D</bold>), DKK3 (<bold>E</bold>, <bold>F</bold>), and WNT5A (<bold>G</bold>, <bold>H</bold>) in normal donor (ND) (<bold>A</bold>, <bold>C</bold>, <bold>E</bold>, <bold>G</bold>) and OA (<bold>B</bold>, <bold>D</bold>, <bold>F</bold>, <bold>H</bold>) cartilage. Nuclei were stained blue with 4’,6-diamidino-2-phenylindol.</p>
</caption>
<graphic xlink:href="10.1177_1947603511414178-fig3.tif"/>
</fig>
</sec>
<sec id="section19-1947603511414178">
<title>WNT Signal Transduction Pathway Differentially Expressed in OA Cartilage</title>
<p>The protein-protein interaction network analysis of genes, classified both as signal transducers and differentially expressed in OA cartilage (performed with raw data originated from the microarray analysis), revealed 7 hub genes associated with the WNT signaling pathway including the receptors <italic>FZD1</italic>, <italic>FZD7</italic>, <italic>FZD8</italic>, and <italic>FZD10</italic>; the extracellular inhibitors <italic>SFRP1</italic> and <italic>SFRPP4</italic>; and the ligand <italic>WNT5A</italic> (<xref ref-type="fig" rid="fig4-1947603511414178"><bold>Fig. 4</bold></xref>). The presence of these hub genes demonstrates that the WNT signaling pathway is dysregulated in OA cartilage (for more general information, see <xref ref-type="table" rid="table4-1947603511414178"><bold>Table 4</bold></xref>).</p>
<fig id="fig4-1947603511414178" position="float">
<label>Figure 4.</label>
<caption>
<p>Protein-protein interaction network of genes differentially regulated comparing OA and ND cartilage and classified as signal transducers, generated with the STRING search tool. Hub genes linked to WNT signaling, identified as genes with interaction with at least 5 other regulated genes, are marked in red. Other WNT-associated genes are marked by yellow boxes.</p>
</caption>
<graphic xlink:href="10.1177_1947603511414178-fig4.tif"/>
</fig>
<table-wrap id="table4-1947603511414178" position="float">
<label>Table 4.</label>
<caption>
<p>Genes Revealed in the Protein-Protein Interaction Analysis</p>
</caption>
<graphic alternate-form-of="table4-1947603511414178" xlink:href="10.1177_1947603511414178-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Gene Name</th>
<th align="center">Gene Symbol</th>
<th align="center">Probe ID</th>
<th align="center">Public ID</th>
<th align="center">FC OA versus ND</th>
<th align="center"><italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Interleukin 8</td>
<td>IL8</td>
<td>211506_s_at</td>
<td>AF043337</td>
<td>136.4</td>
<td>6.68882E-20</td>
</tr>
<tr>
<td>Chemokine ligand 4</td>
<td>CCL4</td>
<td>204103_at</td>
<td>NM_002984</td>
<td>29.1</td>
<td>1.38807E-17</td>
</tr>
<tr>
<td>Adenylate cyclase 7</td>
<td>ADCY7</td>
<td>203741_s_at</td>
<td>NM_001114</td>
<td>28.6</td>
<td>1.09951E-16</td>
</tr>
<tr>
<td>Fc fragment of IgE, high affinity I, receptor for γ polypeptide</td>
<td>FCER1G</td>
<td>1554899_s_at</td>
<td align="center">—</td>
<td>20.4</td>
<td>5.63102E-12</td>
</tr>
<tr>
<td>Insulin-like growth factor 1</td>
<td>IGF1</td>
<td>209541_at</td>
<td>AI972496</td>
<td>17.6</td>
<td>4.53068E-8</td>
</tr>
<tr>
<td>Phosphodiesterase 4B, cAMP specific</td>
<td>PDE4B</td>
<td>203708_at</td>
<td>NM_002600</td>
<td>16.8</td>
<td>2.47481E-16</td>
</tr>
<tr>
<td>Wingless-type MMTV integration site family, member 5</td>
<td>WNT5A</td>
<td>205990_s_at</td>
<td>NM_003392</td>
<td>16.0</td>
<td>6.92735E-15</td>
</tr>
<tr>
<td>Secreted frizzled-related protein 4</td>
<td>SFRP4</td>
<td>204051_s_at</td>
<td>AW089415</td>
<td>14.2</td>
<td>1.38979E-25</td>
</tr>
<tr>
<td>Frizzled homolog 8</td>
<td>FZD8</td>
<td>227405_s_at</td>
<td>AW340311</td>
<td>13.4</td>
<td>8.92757E-26</td>
</tr>
<tr>
<td>Insulin-like growth factor binding protein 4</td>
<td>IGFBP4</td>
<td>201508_at</td>
<td>NM_001552</td>
<td>11.0</td>
<td>7.25381E-12</td>
</tr>
<tr>
<td>Interleukin-1β</td>
<td>IL1B</td>
<td>205067_at</td>
<td>NM_000576</td>
<td>10.4</td>
<td>4.28733E-16</td>
</tr>
<tr>
<td>Guanylate cyclase 1, soluble, α 3</td>
<td>GUCY1A3</td>
<td>221942_s_at</td>
<td>AI719730</td>
<td>9.6</td>
<td>1.45456E-12</td>
</tr>
<tr>
<td>Chloride intracellular channel 3</td>
<td>CLIC3</td>
<td>219529_at</td>
<td>NM_004669</td>
<td>8.4</td>
<td>3.06828E-9</td>
</tr>
<tr>
<td>Secreted frizzled-related protein 1</td>
<td>SFRP1</td>
<td>202037_s_at</td>
<td>NM_003012</td>
<td>8.1</td>
<td>1.45767E-12</td>
</tr>
<tr>
<td>Chemokine (C-X-C motif) ligand 1</td>
<td>CXCL1</td>
<td>204470_at</td>
<td>NM_001511</td>
<td>7.9</td>
<td>2.24479E-15</td>
</tr>
<tr>
<td>ADP ribosylation factor–like 4A</td>
<td>ARL4A</td>
<td>205020_s_at</td>
<td>NM_005738</td>
<td>7.3</td>
<td>3.32194E-9</td>
</tr>
<tr>
<td>Neuropilin 1</td>
<td>NRP1</td>
<td>210510_s_at</td>
<td>AF145712</td>
<td>6.9</td>
<td>2.562E-14</td>
</tr>
<tr>
<td>Frizzled homolog 10</td>
<td>FZD10</td>
<td>219764_at</td>
<td>NM_007197</td>
<td>6.7</td>
<td>6.72813E-30</td>
</tr>
<tr>
<td>Endothelial differentiation, sphingolipid G protein–coupled receptor 3</td>
<td>EDG3</td>
<td>228176_at</td>
<td align="center">—</td>
<td>6.4</td>
<td>1.98944E-10</td>
</tr>
<tr>
<td>Fibroblast growth factor 1</td>
<td>FGF1</td>
<td>205117_at</td>
<td>X59065</td>
<td>6.3</td>
<td>6.13851E-12</td>
</tr>
<tr>
<td>Vascular endothelial growth factor C</td>
<td>VEGFC</td>
<td>209946_at</td>
<td>U58111</td>
<td>5.8</td>
<td>1.9044E-15</td>
</tr>
<tr>
<td>Insulin-like growth factor binding protein 5</td>
<td>IGFBP5</td>
<td>211959_at</td>
<td>AW007532</td>
<td>5.5</td>
<td>4.0204E-28</td>
</tr>
<tr>
<td>Interleukin-1 receptor–associated kinase 2</td>
<td>IRAK2</td>
<td>231779_at</td>
<td>AI246590</td>
<td>5.5</td>
<td>5.16393E-10</td>
</tr>
<tr>
<td>Guanine nucleotide binding protein γ 2</td>
<td>GNG2</td>
<td>224964_s_at</td>
<td>AK026424</td>
<td>5.2</td>
<td>4.62131E-13</td>
</tr>
<tr>
<td>Heparin-binding EGF-like growth factor</td>
<td>HBEGF</td>
<td>38037_at</td>
<td>M60278</td>
<td>4.9</td>
<td>9.22139E-11</td>
</tr>
<tr>
<td>Guanine nucleotide binding protein γ 11</td>
<td>GNG11</td>
<td>204115_at</td>
<td>NM_004126</td>
<td>4.8</td>
<td>1.66689E-15</td>
</tr>
<tr>
<td>EPH receptor A3</td>
<td>EPHA3</td>
<td>206070_s_at</td>
<td>AF213459</td>
<td>4.7</td>
<td>1.71399E-8</td>
</tr>
<tr>
<td>Lymphocyte antigen 96</td>
<td>LY96</td>
<td>206584_at</td>
<td>NM_015364</td>
<td>4.3</td>
<td>8.90125E-14</td>
</tr>
<tr>
<td>Insulin-like growth factor binding protein 3</td>
<td>IGFBP3</td>
<td>212143_s_at</td>
<td>BF340228</td>
<td>4.2</td>
<td>5.24352E-10</td>
</tr>
<tr>
<td>Frizzled homolog 7</td>
<td>FZD7</td>
<td>203706_s_at</td>
<td>NM_003507</td>
<td>4.0</td>
<td>3.13684E-24</td>
</tr>
<tr>
<td>Guanylate cyclase 1, soluble, β 3</td>
<td>GUCY1B3</td>
<td>211555_s_at</td>
<td>AF020340</td>
<td>3.9</td>
<td>8.58847E-8</td>
</tr>
<tr>
<td>Deleted in liver cancer 1</td>
<td>DLC1</td>
<td>210762_s_at</td>
<td>AF026219</td>
<td>3.9</td>
<td>2.07307E-11</td>
</tr>
<tr>
<td>Frizzled homolog 1</td>
<td>FZD1</td>
<td>204452_s_at</td>
<td>AF072872</td>
<td>3.8</td>
<td>3.07887E-13</td>
</tr>
<tr>
<td>Toll-like receptor 4</td>
<td>TLR4</td>
<td>221060_s_at</td>
<td>NM_003266</td>
<td>3.7</td>
<td>1.04917E-8</td>
</tr>
<tr>
<td>Cell division cycle 42</td>
<td>CDC42</td>
<td>210232_at</td>
<td>M35543</td>
<td>3.7</td>
<td>1.28184E-13</td>
</tr>
<tr>
<td>Casein kinase I ϵ</td>
<td>CSNK1E</td>
<td>226858_at</td>
<td align="center">—</td>
<td>3.5</td>
<td>2.73695E-8</td>
</tr>
<tr>
<td>T-cell lymphoma invasion and metastasis 1</td>
<td>TIAM1</td>
<td>213135_at</td>
<td>U90902</td>
<td>3.5</td>
<td>2.20078E-11</td>
</tr>
<tr>
<td>Nuclear factor of κ light polypeptide gene enhancer in B-cells 1</td>
<td>NFκB1</td>
<td>209239_at</td>
<td>M55643</td>
<td>3.4</td>
<td>7.31975E-11</td>
</tr>
<tr>
<td>EPH receptor A2</td>
<td>EPHA2</td>
<td>203499_at</td>
<td>NM_004431</td>
<td>3.4</td>
<td>1.24766E-8</td>
</tr>
<tr>
<td>Receptor-interacting serine-threonine kinase 2</td>
<td>RIPK2</td>
<td>209545_s_at</td>
<td>AF064824</td>
<td>3.4</td>
<td>6.04088E-12</td>
</tr>
<tr>
<td>Rho GDP dissociation inhibitor β</td>
<td>ARHGDIB</td>
<td>1555812_a_at</td>
<td align="center">—</td>
<td>3.1</td>
<td>1.29293E-12</td>
</tr>
<tr>
<td>WNT inhibitory factor 1</td>
<td>WIF1</td>
<td>204712_at</td>
<td>NM_007191</td>
<td>3.1</td>
<td>2.26111E-5</td>
</tr>
<tr>
<td>ADP ribosylation factor 6</td>
<td>ARF6</td>
<td>203312_x_at</td>
<td>NM_001663</td>
<td>2.3</td>
<td>1.20473E-10</td>
</tr>
<tr>
<td>Period homolog 1</td>
<td>PER1</td>
<td>36829_at</td>
<td>AF022991</td>
<td>−2.6</td>
<td>4.15062E-16</td>
</tr>
<tr>
<td>V-akt murine thymoma viral oncogene homolog 3</td>
<td>AKT3</td>
<td>212607_at</td>
<td>N32526</td>
<td>−3.0</td>
<td>3.91207E-15</td>
</tr>
<tr>
<td>Very low density lipoprotein receptor</td>
<td>VLDLR</td>
<td>209822_s_at</td>
<td>L22431</td>
<td>−3.2</td>
<td>3.87155E-14</td>
</tr>
<tr>
<td>CD79b molecule, immunoglobulin-associated β</td>
<td>CD79B</td>
<td>205297_s_at</td>
<td>NM_000626</td>
<td>−3.3</td>
<td>1.07823E-10</td>
</tr>
<tr>
<td>Phosphoinositide 3-kinase, regulatory subunit 1</td>
<td>PIK3R1</td>
<td>212249_at</td>
<td>AI934473</td>
<td>−4.2</td>
<td>9.10041E-13</td>
</tr>
<tr>
<td>Tripartite motif containing 23</td>
<td>TRIM23</td>
<td>210994_x_at</td>
<td>AF230398</td>
<td>−4.5</td>
<td>3.92373E-21</td>
</tr>
<tr>
<td>Neuroepithelial cell transforming 1</td>
<td>NET1</td>
<td>201829_at</td>
<td>AW263232</td>
<td>−4.8</td>
<td>1.24765E-44</td>
</tr>
<tr>
<td>FYVE, RhoGEF and PH domain containing 4</td>
<td>FGD4</td>
<td>230559_x_at</td>
<td>AI277617</td>
<td>−6.7</td>
<td>4.07098E-11</td>
</tr>
<tr>
<td>Interleukin 6 receptor</td>
<td>IL6R</td>
<td>226333_at</td>
<td align="center">—</td>
<td>−6.8</td>
<td>1.22076E-29</td>
</tr>
<tr>
<td>Family with sequence similarity 13, member A</td>
<td>FAM13A1</td>
<td>202973_x_at</td>
<td align="center">—</td>
<td>−7.0</td>
<td>1.13137E-17</td>
</tr>
<tr>
<td>V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog</td>
<td>KIT</td>
<td>205051_s_at</td>
<td>NM_000222</td>
<td>−7.5</td>
<td>4.08763E-9</td>
</tr>
<tr>
<td>Ras homolog gene family, member B</td>
<td>RHOB</td>
<td>1553965_x_at</td>
<td align="center">—</td>
<td>−8.4</td>
<td>7.02128E-17</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-1947603511414178">
<p>Note: All genes, both WNT and non-WNT related, revealed in the protein-protein interaction analysis. Expression differences are given as fold change (FC). Genes with a positive FC are upregulated in osteoarthritic (OA) cartilage when compared with normal donor (ND) cartilage. Performed with raw data originated from the microarray analysis.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section20-1947603511414178">
<title>Increased Expression of DKK1, FOSL1, SFRP4, and WNT5A in Interleukin-1β–Stimulated Chondrocytes</title>
<p>Chondrocytes from both OA and ND cartilage were stimulated with interleukin-1β in order to study if the increased production of this cytokine in OA could explain the increased expression of WNT-related genes. Real-time PCR demonstrated that interleukin-1β stimulation induced significantly increased expression of <italic>FOSL1</italic> and <italic>WNT5A</italic> in chondrocytes derived from both ND and OA cartilage. The same trend was observed in <italic>SFRP4</italic> expression (except for OAChon3) (<xref ref-type="fig" rid="fig5-1947603511414178"><bold>Fig. 5A</bold></xref>-<xref ref-type="fig" rid="fig5-1947603511414178"><bold>C</bold></xref>). No consistent upregulated expression of <italic>DKK1</italic> was detected after interleukin-1β stimulation, while a somewhat downregulated expression of <italic>FZD1</italic> was detected (<xref ref-type="fig" rid="fig5-1947603511414178"><bold>Fig. 5D</bold></xref> and <xref ref-type="fig" rid="fig5-1947603511414178"><bold>5E</bold></xref>). No significant differences in the expression of Wnt markers were detected between ND and OA chondrocytes cultured in monolayer (data not shown).</p>
<fig id="fig5-1947603511414178" position="float">
<label>Figure 5.</label>
<caption>
<p>Real-time PCR analysis after IL-1β stimulation. Gene expression analysis of <italic>FOSL1</italic>, <italic>SFRP4</italic>, <italic>WNT5A</italic>, <italic>DKK1</italic>, and <italic>FZD1</italic> after interleukin-1β stimulation of chondrocytes from normal cartilage (indicated as NDChon1-3 in the chart) and OA cartilage (indicated as OAChon4-6 in the chart). Error bars present the uncertainty with a 95% confidence interval. Cartilage biopsies from 3 normal donors (NDs) and 3 OA donors were studied; each sample was analyzed in duplicates.</p>
</caption>
<graphic xlink:href="10.1177_1947603511414178-fig5.tif"/>
</fig>
</sec>
</sec>
<sec id="section21-1947603511414178" sec-type="discussion">
<title>Discussion</title>
<p>This study is the first that comprehensively analyzed the expression of WNT markers in human OA cartilage using genome-wide microarrays. We have earlier reported the results from a broad gene expression comparison of ND and OA cartilage and here focus on the expression of WNT markers.<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup> One important issue in this type of study is the source of biological material. In this study, we chose to analyze cartilage obtained <italic>post mortem</italic> from donors having no history of OA as well as patients diagnosed with OA. One drawback with this approach is that there is a difference in age between the 2 groups of donors compared, and it is further possible that these 2 groups of donors have different levels of physical activity. Both these factors can, of course, affect the gene expression of the chondrocytes.<sup><xref ref-type="bibr" rid="bibr23-1947603511414178">23</xref>,<xref ref-type="bibr" rid="bibr24-1947603511414178">24</xref></sup> Another alternative approach is to use macroscopically healthy and diseased cartilage from the same OA patient. This setup overcomes the issues described above, but on the other hand, possible genetic differences will not be detected, and what macroscopically appears to be healthy cartilage might still differ from “true” healthy cartilage. OA is further more common on the medial part of the knee so taking OA and ND cartilage from the same joint will thus likely result in a comparison of cartilage from different parts of the knee, which also is known to affect gene expression.<sup><xref ref-type="bibr" rid="bibr25-1947603511414178">25</xref>,<xref ref-type="bibr" rid="bibr26-1947603511414178">26</xref></sup> We have characterized our biopsies both macroscopically, microscopically, as well as using whole-genome microarray analysis and demonstrated typical traits of ND and OA cartilage as seen in the literature<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref>,<xref ref-type="bibr" rid="bibr27-1947603511414178">27</xref></sup> and therefore consider the differences detected in WNT signaling in our study highly likely to be due to OA.</p>
<p>The KEGG pathway analysis, demonstrating differently expressed WNT signaling in OA compared to ND cartilage, encouraged us to further investigate the WNT pathway. This approach resulted in the discovery of an array of WNT-related genes, not previously associated with OA, displaying significantly altered expression in OA compared to ND human articular cartilage. Besides the results from the pathway analysis, the main finding of this study is the discovery of a panel of inhibitors of the canonical and planar cell polarity pathways displaying significantly increased expression in OA cartilage. Moreover, the protein-protein interaction network analysis, demonstrating that several hub genes within the WNT signaling pathway were dysregulated in OA compared to ND cartilage, gave further indications of a different signaling profile in OA-affected cartilage. Our results further demonstrate that the expression of several of these genes significantly increased after cytokine treatment, which at least partly might explain their increased expression in OA cartilage. In fact, the expression of IL-β was significantly increased (10.4 FC) in OA compared to healthy cartilage (<xref ref-type="table" rid="table4-1947603511414178"><bold>Table 4</bold></xref>). Moreover, previous studies have demonstrated upregulation of several WNT-related genes associated with IL-1β stimulation.<sup><xref ref-type="bibr" rid="bibr13-1947603511414178">13</xref>,<xref ref-type="bibr" rid="bibr28-1947603511414178">28</xref>,<xref ref-type="bibr" rid="bibr29-1947603511414178">29</xref></sup></p>
<p>In this study, both <italic>DKK1</italic> and <italic>DKK3</italic> were found to be highly expressed in OA cartilage. DKK1 interacts with LRP5 and LRP6 and the transmembrane receptors KRM1 and KRM2 and prevents activation of the canonical WNT network.<sup><xref ref-type="bibr" rid="bibr30-1947603511414178">30</xref></sup> In accordance with our results, increased serum levels of DKK1 have been detected in patients with OA,<sup><xref ref-type="bibr" rid="bibr28-1947603511414178">28</xref>,<xref ref-type="bibr" rid="bibr31-1947603511414178">31</xref></sup> and it is likely that DKK1 detected in serum originates from the OA-affected cartilage. However, the impact of this increased expression is still unknown, but it has been associated both with reduced risk for cartilage loss<sup><xref ref-type="bibr" rid="bibr31-1947603511414178">31</xref></sup> and chondrocyte apoptosis.<sup><xref ref-type="bibr" rid="bibr28-1947603511414178">28</xref></sup> Additionally, in line with our results, Meng <italic>et al.</italic> observed an upregulation of DKK3 in experimentally induced OA cartilage.<sup><xref ref-type="bibr" rid="bibr32-1947603511414178">32</xref></sup></p>
<p>Our microarray data further demonstrated increased expression of other extracellular inhibitors of canonical WNT signaling, including <italic>WIF1</italic>, <italic>SFRP1</italic>, and <italic>SFRP4</italic> (results for <italic>SFRP1</italic> and <italic>SFRP4</italic> were also verified by real-time PCR). Verification by immunohistological stainings revealed expression of DKK1 and DKK3 in the entire sections of OA cartilage, but only in the surface zone in ND cartilage. This could be due to the phenotypic and metabolic changes that OA chondrocytes display among the zones in articular cartilage compared to ND chondrocytes. WIF1 and SFRP are antagonists to the WNT signaling network, resulting in an inhibition of both the canonical and planar cell polarity pathways.<sup><xref ref-type="bibr" rid="bibr33-1947603511414178">33</xref></sup> Moreover, the protein interaction analysis conducted in this study revealed interactions between <italic>FZD8</italic>, <italic>SFRP1</italic>, and <italic>SFRP4</italic>, which give further support to the suggestion of inhibited WNT pathways. Our study is the first demonstrating WIF1 in OA cartilage, while both SFRP1 and SFRP4 have earlier been detected in OA synovium<sup><xref ref-type="bibr" rid="bibr34-1947603511414178">34</xref></sup> but have not previously been associated with OA chondrocytes. SFRP1, SFRP3, and SFRP5 have recently been demonstrated to be expressed in proliferating chondrocytes and at the prehypertrophic stage during mouse limb formation.<sup><xref ref-type="bibr" rid="bibr7-1947603511414178">7</xref></sup> The significantly increased expression of <italic>SFRP1</italic> and <italic>SFRP4</italic> detected in OA cartilage might thus result in increased proliferation and hypertrophy characteristic of OA cartilage. Our results further demonstrate that the increased expression of <italic>DKK1</italic>, <italic>FOSL1</italic>, <italic>SFRP4</italic>, and <italic>WNT5A</italic> in OA cartilage might partly be due to the increased release of cytokines characteristic of OA chondrocytes. In accordance with our data, Weng <italic>et al</italic>. have correlated both tumor necrosis factor-α and interleukin-1β production to DKK1 expression in OA cartilage.<sup><xref ref-type="bibr" rid="bibr28-1947603511414178">28</xref></sup></p>
<p>Other signs of an inhibited canonical WNT signaling pathway in OA cartilage were suggested in this study by a high expression of several genes involved in β-catenin phosphorylation and its destruction, such as <italic>AXIN2</italic>, <italic>SOX17</italic>, and <italic>TAX1BP3</italic>. AXIN2 expression has been reported to increase in response to mechanical injury to human articular cartilage<sup><xref ref-type="bibr" rid="bibr35-1947603511414178">35</xref></sup> and is known to assemble proteins involved in β-catenin phosphorylation and degradation. AXIN2 has further been suggested to participate in a negative feedback loop limiting the duration/intensity of a WNT-initiated signal.<sup><xref ref-type="bibr" rid="bibr36-1947603511414178">36</xref>,<xref ref-type="bibr" rid="bibr37-1947603511414178">37</xref></sup> Immunohistological staining performed in our study exhibited expression of AXIN2 in the uppermost layers of ND cartilage; meanwhile, OA cartilage displayed AXIN2 expression in the entire section, which could implicate that AXIN2 promotes restriction of WNT network signals in OA cartilage. SOX17 interacts directly with both β-catenin and TCF/LEF to trigger degradation of the β-catenin complex, thus inhibiting WNT signaling.<sup><xref ref-type="bibr" rid="bibr38-1947603511414178">38</xref></sup> TAX1BP3, also referred to as TIP1, has been suggested to repress transcriptional activity of β-catenin, possibly by affecting the stability or subcellular localization of β-catenin.<sup><xref ref-type="bibr" rid="bibr39-1947603511414178">39</xref></sup> Taken together, these findings could suggest that the activity/stability of β-catenin is affected in OA cartilage, thus potentially resulting in an inhibited canonical WNT signaling pathway. On the contrary, other studies have reported increased protein expression of β-catenin in human OA cartilage,<sup><xref ref-type="bibr" rid="bibr15-1947603511414178">15</xref></sup> implicating an activated canonical WNT signaling. Additionally, the study also demonstrated significantly higher expression of the noncanonical ligand <italic>WNT5A</italic>, which is in line with our results (see below) and is further suggested by Zhu <italic>et al.</italic> as an upregulation of Ca<sup>2+</sup>/WNT signaling pathway via β-catenin. Although the expression of β-catenin is not ascertained within this study, and we cannot rule out the possibility that downstream signaling is affected by other compensation mechanisms than those revealed in this microarray analysis, this thus suggests that the canonical WNT signaling pathway is partly inhibited in OA cartilage.</p>
<p>Finally, our analysis further revealed an increased expression in OA cartilage of several intranuclear inhibitors of canonical WNT signaling, such as <italic>TLE4</italic>, but also decreased expression of the transcription factor <italic>TCF7L2</italic> (also referred to as <italic>TCF4</italic>). This might result in an inhibited transcription of downstream WNT-related genes. On the other hand, the microarray data demonstrated increased expression in OA cartilage of <italic>FOSL1</italic> and <italic>PPARD.</italic> However, verification of the microarray expression by PCR only revealed a significantly increased expression of <italic>FOSL1</italic> in OA cartilage. <italic>FOSL1</italic> is involved in WNT signaling pathway (according to the KEGG database) and is suggested as a β-catenin/WNT signaling target gene, transcribed when WNT signaling is activated,<sup><xref ref-type="bibr" rid="bibr40-1947603511414178">40</xref>,<xref ref-type="bibr" rid="bibr41-1947603511414178">41</xref></sup> thus implying increased canonical WNT signaling. This is not in accordance with our results obtained for upstream genes within the canonical WNT pathway, suggesting decreased signaling through this pathway, but could thus indicate a partly inhibited canonical WNT signaling pathway. However, this gene is also part of another WNT signaling cascade, the Ca<sup>2+</sup>/WNT signaling pathway,<sup><xref ref-type="bibr" rid="bibr42-1947603511414178">42</xref></sup> which, suggested by our study, was activated in OA cartilage and thus might explain the increased expression of <italic>FOSL1</italic> (see discussion below). FOSL1, also referred to as FRA1, is further also part of the AP1 complex, which has been implicated in the regulation of matrix metalloproteinase 1 (MMP1) expression in OA cartilage.<sup><xref ref-type="bibr" rid="bibr43-1947603511414178">43</xref>,<xref ref-type="bibr" rid="bibr44-1947603511414178">44</xref></sup> Moreover, ectopic expression of FRA1 induces increased bone mass,<sup><xref ref-type="bibr" rid="bibr45-1947603511414178">45</xref></sup> which is interesting because increased subchondral plate thickness is a characteristic of OA pathogenesis. However, because AP-1 genes have further been implicated in the pathogenesis of cancer in various tissues and are commonly activated in response to inflammatory stimuli,<sup><xref ref-type="bibr" rid="bibr46-1947603511414178">46</xref>,<xref ref-type="bibr" rid="bibr47-1947603511414178">47</xref></sup> the high expression in OA cartilage thus not unanimous demonstrates WNT activation.</p>
<p>With regard to markers of the planar cell polarity pathway, our study demonstrated that transcription of the gene encoding the transmembrane protein <italic>VANGL1</italic> was increased in OA cartilage. Furthermore, <italic>DAAM2</italic>, <italic>PRICKLE2</italic>, and <italic>DVL2</italic> encoding cytoplasmatic proteins, interacting with FZD and VANGL1, displayed decreased expression in OA cartilage. It has earlier been demonstrated that the proteins encoded by these genes interact with FZD and VANGL1, forming a multiprotein complex that transmit signaling to the nucleus. The decreased expression of these genes demonstrated in this study suggests not only the canonical WNT signaling pathway as partly inhibited in OA cartilage but also the planar cell polarity pathway.<sup><xref ref-type="bibr" rid="bibr48-1947603511414178">48</xref></sup> However, our study further suggests that the Ca<sup>2+</sup>/WNT signaling pathway was activated in OA cartilage. This was demonstrated by increased expression of the <italic>WNT5A</italic> ligand in OA cartilage, causing intracellular calcium flux leading to activation of Ca<sup>2+</sup>-dependent effector molecules such as <italic>CAMKII</italic>, <italic>NFAT5</italic>, and <italic>NFATC2</italic>, which was also demonstrated to be upregulated in OA cartilage. Interestingly, CAMKII has been implicated as a key factor in impact-induced chondrocyte death and presumably acts downstream of an increased concentration of cytoplasmic calcium.<sup><xref ref-type="bibr" rid="bibr49-1947603511414178">49</xref></sup> Moreover, our study demonstrated that real-time PCR verification of the expression of <italic>NFATC2</italic> and <italic>WNT5A</italic> was in accordance with the results obtained from the microarray analysis. <italic>NFATC2</italic> is known to regulate chondrogenesis in adult mice, whereas an overexpression represses the mature phenotype and extinguishes the cartilage phenotype.<sup><xref ref-type="bibr" rid="bibr50-1947603511414178">50</xref></sup> Extracellular matrix–degrading proteases have been suggested as downstream targets of <italic>NFATC2</italic> activation.<sup><xref ref-type="bibr" rid="bibr51-1947603511414178">51</xref></sup> This further demonstrates the impact that WNT-related genes exert on the pathogenesis of OA and implicates <italic>NFATC2</italic> in the involvement of the OA chondrocyte phenotypic change and articular cartilage destruction process.</p>
<p>WNT5A microarray expression was further verified by immunohistological staining, demonstrating WNT5A expression in both the superficial zone and the deeper layers of OA cartilage. ND cartilage, on the other hand, displayed a somewhat more restricted WNT5A expression, located in the superficial zone. WNT5A has earlier been shown to exert an inhibitory effect on type II collagen expression in chondrocytes and is indicated to increase in gene expression related to IL-1β stimulation.<sup><xref ref-type="bibr" rid="bibr13-1947603511414178">13</xref>,<xref ref-type="bibr" rid="bibr29-1947603511414178">29</xref></sup> This is in accordance with our result that demonstrated a significantly higher <italic>WNT5A</italic> expression after cytokine stimulation. Increased <italic>WNT5A</italic> expression associated with IL-1β stimulation is further implicated in the regulation of MMPs responsible for promoting cartilage destruction.<sup><xref ref-type="bibr" rid="bibr29-1947603511414178">29</xref></sup> This is interesting to note because we have earlier discussed (see above) the involvement of the <italic>FOSL1</italic>, a suggested downstream target gene of Ca<sup>2+</sup>/WNT signaling pathway, in the regulation of MMP1.</p>
<p>This and the suggested activation of the Ca<sup>2+</sup>/WNT signaling pathway and its effector molecules in OA cartilage could thus, to some extent, explain the increased apoptosis detected in OA chondrocytes as well as the altered matrix composition seen in OA cartilage. Our data, which is an extension of a previously published article,<sup><xref ref-type="bibr" rid="bibr17-1947603511414178">17</xref></sup> provide a basis for future studies on the function of numerous newly identified genes in OA pathogenesis and on their suitability as drug targets in OA.</p>
</sec>
<sec id="section22-1947603511414178" sec-type="conclusions">
<title>Conclusion</title>
<p>Our results demonstrate that WNT signaling is significantly altered in OA cartilage. The result suggests that the canonical and planar cell polarity pathways are partly inhibited while the Ca<sup>2+</sup>/WNT signaling pathway is activated.</p>
</sec>
</body>
<back>
<ack><p>The authors thank Anja Wachtel and Sven Schurig for excellent technical assistance.</p></ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This work was supported by the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, Region Västra Götaland, Swedish Research Council (K2009-52X-09495-22-3 and 2005-7544), and the EU’s Sixth Framework Programme (Systems Approach to Tissue Engineering Products and Processes [STEPS]; grant NMP3-CT-2005-500465).</p>
</fn>
<fn fn-type="conflict">
<p>The authors declared no potential conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1947603511414178">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peat</surname><given-names>G</given-names></name>
<name><surname>McCarney</surname><given-names>R</given-names></name>
<name><surname>Croft</surname><given-names>P</given-names></name>
</person-group>. <article-title>Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care</article-title>. <source>Ann Rheum Dis</source>. <year>2001</year>;<volume>60</volume>:<fpage>91</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr2-1947603511414178">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ehrlich</surname><given-names>MG</given-names></name>
<name><surname>Mankin</surname><given-names>HJ</given-names></name>
<name><surname>Jones</surname><given-names>H</given-names></name>
<name><surname>Wright</surname><given-names>R</given-names></name>
<name><surname>Crispen</surname><given-names>C</given-names></name>
<name><surname>Vigliani</surname><given-names>G</given-names></name>
</person-group>. <article-title>Collagenase and collagenase inhibitors in osteoarthritic and normal cartilage</article-title>. <source>J Clin Invest</source>. <year>1977</year>;<volume>59</volume>:<fpage>226</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr3-1947603511414178">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goldring</surname><given-names>MB</given-names></name>
<name><surname>Goldring</surname><given-names>SR</given-names></name>
</person-group>. <article-title>Osteoarthritis</article-title>. <source>J Cell Physiol</source>. <year>2007</year>;<volume>213</volume>:<fpage>626</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr4-1947603511414178">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komiya</surname><given-names>Y</given-names></name>
<name><surname>Habas</surname><given-names>R</given-names></name>
</person-group>. <article-title>Wnt signal transduction pathways</article-title>. <source>Organogenesis</source>. <year>2008</year>;<volume>4</volume>:<fpage>68</fpage>-<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr5-1947603511414178">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gordon</surname><given-names>MD</given-names></name>
<name><surname>Nusse</surname><given-names>R</given-names></name>
</person-group>. <article-title>Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>:<fpage>22429</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr6-1947603511414178">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Katoh</surname><given-names>M</given-names></name>
</person-group>. <article-title>WNT signaling pathway and stem cell signaling network</article-title>. <source>Clin Cancer Res</source>. <year>2007</year>;<volume>13</volume>:<fpage>4042</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr7-1947603511414178">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Witte</surname><given-names>F</given-names></name>
<name><surname>Dokas</surname><given-names>J</given-names></name>
<name><surname>Neuendorf</surname><given-names>F</given-names></name>
<name><surname>Mundlos</surname><given-names>S</given-names></name>
<name><surname>Stricker</surname><given-names>S</given-names></name>
</person-group>. <article-title>Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation</article-title>. <source>Gene Expr Patterns</source>. <year>2009</year>;<volume>9</volume>:<fpage>215</fpage>-<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr8-1947603511414178">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Church</surname><given-names>V</given-names></name>
<name><surname>Nohno</surname><given-names>T</given-names></name>
<name><surname>Linker</surname><given-names>C</given-names></name>
<name><surname>Marcelle</surname><given-names>C</given-names></name>
<name><surname>Francis-West</surname><given-names>P</given-names></name>
</person-group>. <article-title>Wnt regulation of chondrocyte differentiation</article-title>. <source>J Cell Sci</source>. <year>2002</year>;<volume>115</volume>:<fpage>4809</fpage>-<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr9-1947603511414178">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tufan</surname><given-names>AC</given-names></name>
<name><surname>Daumer</surname><given-names>KM</given-names></name>
<name><surname>Tuan</surname><given-names>RS</given-names></name>
</person-group>. <article-title>Frizzled-7 and limb mesenchymal chondrogenesis: effect of misexpression and involvement of N-cadherin</article-title>. <source>Dev Dyn</source>. <year>2002</year>;<volume>223</volume>:<fpage>241</fpage>-<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr10-1947603511414178">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stott</surname><given-names>NS</given-names></name>
<name><surname>Jiang</surname><given-names>TX</given-names></name>
<name><surname>Chuong</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Successive formative stages of precartilaginous mesenchymal condensations in vitro: modulation of cell adhesion by Wnt-7A and BMP-2</article-title>. <source>J Cell Physiol</source>. <year>1999</year>;<volume>180</volume>:<fpage>314</fpage>-<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr11-1947603511414178">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Daumer</surname><given-names>KM</given-names></name>
<name><surname>Tufan</surname><given-names>AC</given-names></name>
<name><surname>Tuan</surname><given-names>RS</given-names></name>
</person-group>. <article-title>Long-term in vitro analysis of limb cartilage development: involvement of Wnt signaling</article-title>. <source>J Cell Biochem</source>. <year>2004</year>;<volume>93</volume>:<fpage>526</fpage>-<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr12-1947603511414178">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hartmann</surname><given-names>C</given-names></name>
<name><surname>Tabin</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton</article-title>. <source>Cell</source>. <year>2001</year>;<volume>104</volume>:<fpage>341</fpage>-<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr13-1947603511414178">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ryu</surname><given-names>JH</given-names></name>
<name><surname>Chun</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Opposing roles of WNT-5A and WNT-11 in interleukin-1beta regulation of type II collagen expression in articular chondrocytes</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>:<fpage>22039</fpage>-<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr14-1947603511414178">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SJ</given-names></name>
<name><surname>Im</surname><given-names>DS</given-names></name>
<name><surname>Kim</surname><given-names>SH</given-names></name>
<name><surname>Ryu</surname><given-names>JH</given-names></name>
<name><surname>Hwang</surname><given-names>SG</given-names></name>
<name><surname>Seong</surname><given-names>JK</given-names></name>
<etal/>
</person-group>. <article-title>Beta-catenin regulates expression of cyclooxygenase-2 in articular chondrocytes</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2002</year>;<volume>296</volume>:<fpage>221</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr15-1947603511414178">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>M</given-names></name>
<name><surname>Tang</surname><given-names>D</given-names></name>
<name><surname>Wu</surname><given-names>Q</given-names></name>
<name><surname>Hao</surname><given-names>S</given-names></name>
<name><surname>Chen</surname><given-names>M</given-names></name>
<name><surname>Xie</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice</article-title>. <source>J Bone Miner Res</source>. <year>2009</year>;<volume>24</volume>:<fpage>12</fpage>-<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr16-1947603511414178">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hopwood</surname><given-names>B</given-names></name>
<name><surname>Tsykin</surname><given-names>A</given-names></name>
<name><surname>Findlay</surname><given-names>DM</given-names></name>
<name><surname>Fazzalari</surname><given-names>NL</given-names></name>
</person-group>. <article-title>Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling</article-title>. <source>Arthritis Res Ther</source>. <year>2007</year>;<volume>9</volume>:<fpage>R100</fpage>.</citation>
</ref>
<ref id="bibr17-1947603511414178">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karlsson</surname><given-names>C</given-names></name>
<name><surname>Dehne</surname><given-names>T</given-names></name>
<name><surname>Lindahl</surname><given-names>A</given-names></name>
<name><surname>Brittberg</surname><given-names>M</given-names></name>
<name><surname>Pruss</surname><given-names>A</given-names></name>
<name><surname>Sittinger</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2010</year>;<volume>18</volume>:<fpage>581</fpage>-<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr18-1947603511414178">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Camon</surname><given-names>E</given-names></name>
<name><surname>Magrane</surname><given-names>M</given-names></name>
<name><surname>Barrell</surname><given-names>D</given-names></name>
<name><surname>Lee</surname><given-names>V</given-names></name>
<name><surname>Dimmer</surname><given-names>E</given-names></name>
<name><surname>Maslen</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>The Gene Ontology Annotation (GOA) Database: sharing knowledge in UniProt with gene ontology</article-title>. <source>Nucleic Acids Res</source>. <year>2004</year>;<volume>32</volume>:<fpage>D262</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr19-1947603511414178">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kanehisa</surname><given-names>M</given-names></name>
<name><surname>Goto</surname><given-names>S</given-names></name>
<name><surname>Hattori</surname><given-names>M</given-names></name>
<name><surname>Aoki-Kinoshita</surname><given-names>KF</given-names></name>
<name><surname>Itoh</surname><given-names>M</given-names></name>
<name><surname>Kawashima</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>From genomics to chemical genomics: new developments in KEGG</article-title>. <source>Nucleic Acids Res</source>. <year>2006</year>;<volume>34</volume>:<fpage>D354</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr20-1947603511414178">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang da</surname><given-names>W</given-names></name>
<name><surname>Sherman</surname><given-names>BT</given-names></name>
<name><surname>Lempicki</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title>. <source>Nucleic Acids Res</source>. <year>2009</year>; <volume>37</volume>:<fpage>1</fpage>-<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr21-1947603511414178">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>DW</given-names></name>
<name><surname>Sherman</surname><given-names>BT</given-names></name>
<name><surname>Lempicki</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat Protoc</source>. <year>2009</year>;<volume>4</volume>:<fpage>44</fpage>-<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr22-1947603511414178">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brittberg</surname><given-names>M</given-names></name>
<name><surname>Lindahl</surname><given-names>A</given-names></name>
<name><surname>Nilsson</surname><given-names>A</given-names></name>
<name><surname>Ohlsson</surname><given-names>C</given-names></name>
<name><surname>Isaksson</surname><given-names>O</given-names></name>
<name><surname>Peterson</surname><given-names>L</given-names></name>
</person-group>. <article-title>Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation</article-title>. <source>N Engl J Med</source>. <year>1994</year>;<volume>331</volume>:<fpage>889</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr23-1947603511414178">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leong</surname><given-names>DJ</given-names></name>
<name><surname>Gu</surname><given-names>XI</given-names></name>
<name><surname>Li</surname><given-names>YH</given-names></name>
<name><surname>Lee</surname><given-names>JY</given-names></name>
<name><surname>Laudier</surname><given-names>DM</given-names></name>
<name><surname>Majeska</surname><given-names>RJ</given-names></name>
<etal/>
</person-group>. <article-title>Matrix metalloproteinase-3 in articular cartilage is upregulated by joint immobilization and suppressed by passive joint motion</article-title>. <source>Matrix Biol</source>. <year>2010</year>;<volume>29</volume>:<fpage>420</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr24-1947603511414178">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adkisson</surname><given-names>HD</given-names></name>
<name><surname>Martin</surname><given-names>JA</given-names></name>
<name><surname>Amendola</surname><given-names>RL</given-names></name>
<name><surname>Milliman</surname><given-names>C</given-names></name>
<name><surname>Mauch</surname><given-names>KA</given-names></name>
<name><surname>Katwal</surname><given-names>AB</given-names></name>
<etal/>
</person-group>. <article-title>The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage</article-title>. <source>Am J Sports Med</source>. <year>2010</year>;<volume>38</volume>:<fpage>1324</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr25-1947603511414178">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neame</surname><given-names>R</given-names></name>
<name><surname>Zhang</surname><given-names>W</given-names></name>
<name><surname>Deighton</surname><given-names>C</given-names></name>
<name><surname>Doherty</surname><given-names>M</given-names></name>
<name><surname>Doherty</surname><given-names>S</given-names></name>
<name><surname>Lanyon</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Distribution of radiographic osteoarthritis between the right and left hands, hips, and knees</article-title>. <source>Arthritis Rheum</source>. <year>2004</year>;<volume>50</volume>:<fpage>1487</fpage>-<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr26-1947603511414178">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Salzmann</surname><given-names>GM</given-names></name>
<name><surname>Buchberger</surname><given-names>MS</given-names></name>
<name><surname>Stoddart</surname><given-names>MJ</given-names></name>
<name><surname>Grad</surname><given-names>S</given-names></name>
<name><surname>Milz</surname><given-names>S</given-names></name>
<name><surname>Niemyer</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Varying regional topology within knee articular chondrocytes under simulated in vivo conditions</article-title>. <source>Tissue Eng Part A</source>. <year>2011</year>;<volume>17</volume>:<fpage>451</fpage>-<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr27-1947603511414178">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hissnauer</surname><given-names>TN</given-names></name>
<name><surname>Baranowsky</surname><given-names>A</given-names></name>
<name><surname>Pestka</surname><given-names>JM</given-names></name>
<name><surname>Streichert</surname><given-names>T</given-names></name>
<name><surname>Wiegandt</surname><given-names>K</given-names></name>
<name><surname>Goepfert</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Identification of molecular markers for articular cartilage</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2010</year>; <volume>18</volume>:<fpage>1630</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr28-1947603511414178">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weng</surname><given-names>LH</given-names></name>
<name><surname>Wang</surname><given-names>CJ</given-names></name>
<name><surname>Ko</surname><given-names>JY</given-names></name>
<name><surname>Sun</surname><given-names>YC</given-names></name>
<name><surname>Su</surname><given-names>YS</given-names></name>
<name><surname>Wang</surname><given-names>FS</given-names></name>
</person-group>. <article-title>Inflammation induction of Dickkopf-1 mediates chondrocyte apoptosis in osteoarthritic joint</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2009</year>;<volume>17</volume>:<fpage>933</fpage>-<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr29-1947603511414178">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ge</surname><given-names>X</given-names></name>
<name><surname>Ma</surname><given-names>X</given-names></name>
<name><surname>Meng</surname><given-names>J</given-names></name>
<name><surname>Zhang</surname><given-names>C</given-names></name>
<name><surname>Ma</surname><given-names>K</given-names></name>
<name><surname>Zhou</surname><given-names>C</given-names></name>
</person-group>. <article-title>Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes</article-title>. <source>Arthritis Rheum</source>. <year>2009</year>;<volume>60</volume>:<fpage>2714</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr30-1947603511414178">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mao</surname><given-names>B</given-names></name>
<name><surname>Wu</surname><given-names>W</given-names></name>
<name><surname>Davidson</surname><given-names>G</given-names></name>
<name><surname>Marhold</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>M</given-names></name>
<name><surname>Mechler</surname><given-names>BM</given-names></name>
<etal/>
</person-group>. <article-title>Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling</article-title>. <source>Nature</source>. <year>2002</year>;<volume>417</volume>:<fpage>664</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr31-1947603511414178">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lane</surname><given-names>NE</given-names></name>
<name><surname>Nevitt</surname><given-names>MC</given-names></name>
<name><surname>Lui</surname><given-names>LY</given-names></name>
<name><surname>de Leon</surname><given-names>P</given-names></name>
<name><surname>Corr</surname><given-names>M</given-names></name>
</person-group>. <article-title>Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women</article-title>. <source>Arthritis Rheum</source>. <year>2007</year>;<volume>56</volume>:<fpage>3319</fpage>-<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr32-1947603511414178">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meng</surname><given-names>J</given-names></name>
<name><surname>Ma</surname><given-names>X</given-names></name>
<name><surname>Ma</surname><given-names>D</given-names></name>
<name><surname>Xu</surname><given-names>C</given-names></name>
</person-group>. <article-title>Microarray analysis of differential gene expression in temporomandibular joint condylar cartilage after experimentally induced osteoarthritis</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2005</year>;<volume>13</volume>:<fpage>1115</fpage>-<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr33-1947603511414178">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kawano</surname><given-names>Y</given-names></name>
<name><surname>Kypta</surname><given-names>R</given-names></name>
</person-group>. <article-title>Secreted antagonists of the Wnt signalling pathway</article-title>. <source>J Cell Sci</source>. <year>2003</year>;<volume>116</volume>:<fpage>2627</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr34-1947603511414178">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Imai</surname><given-names>K</given-names></name>
<name><surname>Morikawa</surname><given-names>M</given-names></name>
<name><surname>D’Armiento</surname><given-names>J</given-names></name>
<name><surname>Matsumoto</surname><given-names>H</given-names></name>
<name><surname>Komiya</surname><given-names>K</given-names></name>
<name><surname>Okada</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Differential expression of WNTs and FRPs in the synovium of rheumatoid arthritis and osteoarthritis</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2006</year>;<volume>345</volume>:<fpage>1615</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr35-1947603511414178">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dell’Accio</surname><given-names>F</given-names></name>
<name><surname>De Bari</surname><given-names>C</given-names></name>
<name><surname>El Tawil</surname><given-names>NM</given-names></name>
<name><surname>Barone</surname><given-names>F</given-names></name>
<name><surname>Mitsiadis</surname><given-names>TA</given-names></name>
<name><surname>O’Dowd</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury</article-title>. <source>Arthritis Res Ther</source>. <year>2006</year>;<volume>8</volume>:<fpage>R139</fpage>.</citation>
</ref>
<ref id="bibr36-1947603511414178">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Luo</surname><given-names>W</given-names></name>
<name><surname>Lin</surname><given-names>SC</given-names></name>
</person-group>. <article-title>Axin: a master scaffold for multiple signaling pathways</article-title>. <source>Neurosignals</source>. <year>2004</year>;<volume>13</volume>:<fpage>99</fpage>-<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr37-1947603511414178">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jho</surname><given-names>EH</given-names></name>
<name><surname>Zhang</surname><given-names>T</given-names></name>
<name><surname>Domon</surname><given-names>C</given-names></name>
<name><surname>Joo</surname><given-names>CK</given-names></name>
<name><surname>Freund</surname><given-names>JN</given-names></name>
<name><surname>Costantini</surname><given-names>F</given-names></name>
</person-group>. <article-title>Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway</article-title>. <source>Mol Cell Biol</source>. <year>2002</year>;<volume>22</volume>:<fpage>1172</fpage>-<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr38-1947603511414178">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sinner</surname><given-names>D</given-names></name>
<name><surname>Kordich</surname><given-names>JJ</given-names></name>
<name><surname>Spence</surname><given-names>JR</given-names></name>
<name><surname>Opoka</surname><given-names>R</given-names></name>
<name><surname>Rankin</surname><given-names>S</given-names></name>
<name><surname>Lin</surname><given-names>SC</given-names></name>
<etal/>
</person-group>. <article-title>Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells</article-title>. <source>Mol Cell Biol</source>. <year>2007</year>;<volume>27</volume>:<fpage>7802</fpage>-<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr39-1947603511414178">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kanamori</surname><given-names>M</given-names></name>
<name><surname>Sandy</surname><given-names>P</given-names></name>
<name><surname>Marzinotto</surname><given-names>S</given-names></name>
<name><surname>Benetti</surname><given-names>R</given-names></name>
<name><surname>Kai</surname><given-names>C</given-names></name>
<name><surname>Hayashizaki</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>The PDZ protein tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells</article-title>. <source>J Biol Chem</source>. <year>2003</year>;<volume>278</volume>:<fpage>38758</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr40-1947603511414178">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mann</surname><given-names>B</given-names></name>
<name><surname>Gelos</surname><given-names>M</given-names></name>
<name><surname>Siedow</surname><given-names>A</given-names></name>
<name><surname>Hanski</surname><given-names>ML</given-names></name>
<name><surname>Gratchev</surname><given-names>A</given-names></name>
<name><surname>Ilyas</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1999</year>;<volume>96</volume>:<fpage>1603</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr41-1947603511414178">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X</given-names></name>
<name><surname>Mazanek</surname><given-names>P</given-names></name>
<name><surname>Dam</surname><given-names>V</given-names></name>
<name><surname>Wang</surname><given-names>Q</given-names></name>
<name><surname>Zhao</surname><given-names>H</given-names></name>
<name><surname>Guo</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification</article-title>. <source>Oncogene</source>. <year>2008</year>; <volume>27</volume>:<fpage>1478</fpage>-<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr42-1947603511414178">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaminski</surname><given-names>BA</given-names></name>
<name><surname>Kadereit</surname><given-names>S</given-names></name>
<name><surname>Miller</surname><given-names>RE</given-names></name>
<name><surname>Leahy</surname><given-names>P</given-names></name>
<name><surname>Stein</surname><given-names>KR</given-names></name>
<name><surname>Topa</surname><given-names>DA</given-names></name>
<etal/>
</person-group>. <article-title>Reduced expression of NFAT-associated genes in UCB versus adult CD4(+) T lymphocytes during primary stimulation</article-title>. <source>Blood</source>. <year>2003</year>;<volume>102</volume>:<fpage>4608</fpage>-<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr43-1947603511414178">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Newberry</surname><given-names>EP</given-names></name>
<name><surname>Willis</surname><given-names>D</given-names></name>
<name><surname>Latifi</surname><given-names>T</given-names></name>
<name><surname>Boudreaux</surname><given-names>JM</given-names></name>
<name><surname>Towler</surname><given-names>DA</given-names></name>
</person-group>. <article-title>Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element</article-title>. <source>Mol Endocrinol</source>. <year>1997</year>;<volume>11</volume>:<fpage>1129</fpage>-<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr44-1947603511414178">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Desvergne</surname><given-names>B</given-names></name>
<name><surname>Wahli</surname><given-names>W</given-names></name>
</person-group>. <article-title>Peroxisome proliferator-activated receptors: nuclear control of metabolism</article-title>. <source>Endocr Rev</source>. <year>1999</year>;<volume>20</volume>:<fpage>649</fpage>-<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr45-1947603511414178">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eferl</surname><given-names>R</given-names></name>
<name><surname>Hoebertz</surname><given-names>A</given-names></name>
<name><surname>Schilling</surname><given-names>AF</given-names></name>
<name><surname>Rath</surname><given-names>M</given-names></name>
<name><surname>Karreth</surname><given-names>F</given-names></name>
<name><surname>Kenner</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>The Fos-related antigen Fra-1 is an activator of bone matrix formation</article-title>. <source>EMBO J</source>. <year>2004</year>;<volume>23</volume>:<fpage>2789</fpage>-<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr46-1947603511414178">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eferl</surname><given-names>R</given-names></name>
<name><surname>Wagner</surname><given-names>EF</given-names></name>
</person-group>. <article-title>AP-1: a double-edged sword in tumorigenesis</article-title>. <source>Nat Rev Cancer</source>. <year>2003</year>;<volume>3</volume>:<fpage>859</fpage>-<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr47-1947603511414178">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wagner</surname><given-names>EF</given-names></name>
<name><surname>Eferl</surname><given-names>R</given-names></name>
</person-group>. <article-title>Fos/AP-1 proteins in bone and the immune system</article-title>. <source>Immunol Rev</source>. <year>2005</year>;<volume>208</volume>:<fpage>126</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr48-1947603511414178">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Torban</surname><given-names>E</given-names></name>
<name><surname>Kor</surname><given-names>C</given-names></name>
<name><surname>Gros</surname><given-names>P</given-names></name>
</person-group>. <article-title>Van Gogh-like2 (Strabismus) and its role in planar cell polarity and convergent extension in vertebrates</article-title>. <source>Trends Genet</source>. <year>2004</year>;<volume>20</volume>:<fpage>570</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr49-1947603511414178">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huser</surname><given-names>CA</given-names></name>
<name><surname>Davies</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Calcium signaling leads to mitochondrial depolarization in impact-induced chondrocyte death in equine articular cartilage explants</article-title>. <source>Arthritis Rheum</source>. <year>2007</year>;<volume>56</volume>:<fpage>2322</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr50-1947603511414178">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ranger</surname><given-names>AM</given-names></name>
<name><surname>Gerstenfeld</surname><given-names>LC</given-names></name>
<name><surname>Wang</surname><given-names>JX</given-names></name>
<name><surname>Kon</surname><given-names>T</given-names></name>
<name><surname>Bae</surname><given-names>HS</given-names></name>
<name><surname>Gravallese</surname><given-names>EM</given-names></name>
<etal/>
</person-group>. <article-title>The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis</article-title>. <source>J Exp Med</source>. <year>2000</year>;<volume>191</volume>:<fpage>9</fpage>-<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr51-1947603511414178">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thirunavukkarasu</surname><given-names>K</given-names></name>
<name><surname>Pei</surname><given-names>Y</given-names></name>
<name><surname>Moore</surname><given-names>TL</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Yu</surname><given-names>XP</given-names></name>
<name><surname>Geiser</surname><given-names>AG</given-names></name>
<etal/>
</person-group>. <article-title>Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2006</year>;<volume>345</volume>:<fpage>197</fpage>-<lpage>204</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>